{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:11:48Z","timestamp":1792707108186,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11513-7","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:39:58Z","timestamp":1770287998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Suppressor of cytokine signaling (SOCS) proteins in human retroviral infections"],"prefix":"10.1007","volume":"53","author":[{"given":"Zahra","family":"Farjami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Akbarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1682-8104","authenticated-orcid":false,"given":"Hugo Ram\u00edrez","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"11513_CR1","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.2147\/IJGM.S528870","volume":"18","author":"L Ge","year":"2025","unstructured":"Ge L, Tian X, Sun C, Hu P, Yu M (2025) Pathogenesis of HIV-Associated metabolic syndrome and clinical management recommendations. Int J Gen Med 18:5213\u20135232. https:\/\/doi.org\/10.2147\/IJGM.S528870","journal-title":"Int J Gen Med"},{"key":"11513_CR2","doi-asserted-by":"publisher","unstructured":"Branda F, Romano C, Pavia G, Bilotta V, Locci C, Azzena I et al (2025) Human T-Lymphotropic virus (HTLV): Epidemiology, Genetic, Pathogenesis, and future challenges. Viruses 17(5). https:\/\/doi.org\/10.3390\/v17050664","DOI":"10.3390\/v17050664"},{"key":"11513_CR3","doi-asserted-by":"publisher","unstructured":"Wang Y, Liu M, Guo X, Zhang B, Li H, Liu Y et al (2022) Endogenous retrovirus elements are Co-Expressed with IFN stimulation genes in the JAK-STAT pathway. Viruses 15(1). https:\/\/doi.org\/10.3390\/v15010060","DOI":"10.3390\/v15010060"},{"issue":"6","key":"11513_CR4","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s10787-025-01796-w","volume":"33","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Saad HM, Al-Gareeb AI, Albuhadily AK (2025) Targeting the JAK\/STAT3\/SOCS signaling pathway in alzheimer\u2019s disease. Inflammopharmacology 33(6):2951\u20132962. https:\/\/doi.org\/10.1007\/s10787-025-01796-w","journal-title":"Inflammopharmacology"},{"key":"11513_CR5","doi-asserted-by":"publisher","first-page":"1604271","DOI":"10.3389\/fimmu.2025.1604271","volume":"16","author":"R Cui","year":"2025","unstructured":"Cui R, Zhang J (2025) Research progress of SOCS in autoimmune diseases: mechanisms and therapeutic implications. Front Immunol 16:1604271. https:\/\/doi.org\/10.3389\/fimmu.2025.1604271","journal-title":"Front Immunol"},{"key":"11513_CR6","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.3389\/fmicb.2017.02431","volume":"8","author":"SA Duncan","year":"2017","unstructured":"Duncan SA, Baganizi DR, Sahu R, Singh SR, Dennis VA (2017) SOCS proteins as regulators of inflammatory responses induced by bacterial infections: A review. Front Microbiol 8:2431. https:\/\/doi.org\/10.3389\/fmicb.2017.02431","journal-title":"Front Microbiol"},{"issue":"8","key":"11513_CR7","doi-asserted-by":"publisher","first-page":"e51645","DOI":"10.1002\/eji.202451645","volume":"55","author":"J Herrera-Uribe","year":"2025","unstructured":"Herrera-Uribe J, Stevenson NJ (2025) SOCS proteins: key players in immune regulation during SARS-CoV-2 infection. Eur J Immunol 55(8):e51645. https:\/\/doi.org\/10.1002\/eji.202451645","journal-title":"Eur J Immunol"},{"key":"11513_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000986","author":"BA Peters","year":"2025","unstructured":"Peters BA, Usyk M, Burk RD (2025) The female Microbiome in HIV prevention, pathogenesis, and treatment. Curr Opin HIV AIDS. https:\/\/doi.org\/10.1097\/COH.0000000000000986","journal-title":"Curr Opin HIV AIDS"},{"key":"11513_CR9","doi-asserted-by":"publisher","DOI":"10.2174\/011570162X367092250901062629","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li J, Liu Y (2025) HIV-Associated lymphomas: updates from pathogenesis to treatment strategies. Curr HIV Res. https:\/\/doi.org\/10.2174\/011570162X367092250901062629","journal-title":"Curr HIV Res"},{"issue":"23","key":"11513_CR10","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1101\/gad.1250204","volume":"18","author":"Y Yu","year":"2004","unstructured":"Yu Y, Xiao Z, Ehrlich ES, Yu X, Yu XF (2004) Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev 18(23):2867\u20132872. https:\/\/doi.org\/10.1101\/gad.1250204","journal-title":"Genes Dev"},{"issue":"1","key":"11513_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/2049-632X.12117","volume":"71","author":"MK Lafferty","year":"2014","unstructured":"Lafferty MK, Fantry L, Bryant J, Jones O, Hammoud D, Weitzmann MN et al (2014) Elevated suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated osteoclastogenesis in HIV Transgenic rats. Pathog Dis 71(1):81\u201389. https:\/\/doi.org\/10.1111\/2049-632X.12117","journal-title":"Pathog Dis"},{"key":"11513_CR12","doi-asserted-by":"publisher","first-page":"199539","DOI":"10.1016\/j.virusres.2025.199539","volume":"353","author":"A Amiri","year":"2025","unstructured":"Amiri A, Mardi S, Bahavar A, Sheikhi M, Yaslianifard S, Mozhgani SH (2025) Investigating the circadian rhythm signaling pathway in HTLV-1 pathogenesis using boolean analysis. Virus Res 353:199539. https:\/\/doi.org\/10.1016\/j.virusres.2025.199539","journal-title":"Virus Res"},{"issue":"1","key":"11513_CR13","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1186\/s12885-018-5209-5","volume":"18","author":"H Tarokhian","year":"2018","unstructured":"Tarokhian H, Rahimi H, Mosavat A, Shirdel A, Rafatpanah H, Akbarin MM et al (2018) HTLV-1-host interactions on the development of adult T cell leukemia\/lymphoma: virus and host gene expressions. BMC Cancer 18(1):1287. https:\/\/doi.org\/10.1186\/s12885-018-5209-5","journal-title":"BMC Cancer"},{"key":"11513_CR14","doi-asserted-by":"publisher","first-page":"105622","DOI":"10.1016\/j.micpath.2022.105622","volume":"169","author":"S Ramezani","year":"2022","unstructured":"Ramezani S, Rezaee SA, Farjami Z, Ebrahimi N, Abdullabass HK, Ibrahim Jebur MI et al (2022) HTLV, a multi organ oncovirus. Microb Pathog 169:105622. https:\/\/doi.org\/10.1016\/j.micpath.2022.105622","journal-title":"Microb Pathog"},{"issue":"4","key":"11513_CR15","doi-asserted-by":"publisher","first-page":"e2567","DOI":"10.1002\/rmv.2567","volume":"34","author":"S Ahmadi Ghezeldasht","year":"2024","unstructured":"Ahmadi Ghezeldasht S, Mosavat A, Rezaee SA (2024) Novel insights into human T-lymphotropic virus type-1 (HTLV-1) pathogenesis-host interactions in the manifestation of HTLV-1-associated myelopathy\/tropical spastic paraparesis. Rev Med Virol 34(4):e2567. https:\/\/doi.org\/10.1002\/rmv.2567","journal-title":"Rev Med Virol"},{"issue":"19","key":"11513_CR16","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1182\/blood.2022019332","volume":"141","author":"CRM Bangham","year":"2023","unstructured":"Bangham CRM (2023) HTLV-1 persistence and the oncogenesis of adult T-cell leukemia\/lymphoma. Blood 141(19):2299\u20132306. https:\/\/doi.org\/10.1182\/blood.2022019332","journal-title":"Blood"},{"issue":"1","key":"11513_CR17","doi-asserted-by":"publisher","first-page":"e28424","DOI":"10.1002\/jmv.28424","volume":"95","author":"X Zuo","year":"2023","unstructured":"Zuo X, Zhou R, Yang S, Ma G (2023) HTLV-1 persistent infection and ATLL oncogenesis. J Med Virol 95(1):e28424. https:\/\/doi.org\/10.1002\/jmv.28424","journal-title":"J Med Virol"},{"issue":"2","key":"11513_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.imlet.2007.01.008","volume":"109","author":"A Samaan","year":"2007","unstructured":"Samaan A, Mahana W (2007) Constitutive and induced activation of JAK\/Stat pathway in leukemogenic and asymptomatic human T-cell lymphoptropic virus type 1 (HTLV-1) transformed rabbit cell lines. Immunol Lett 109(2):113\u2013119. https:\/\/doi.org\/10.1016\/j.imlet.2007.01.008","journal-title":"Immunol Lett"},{"key":"11513_CR19","doi-asserted-by":"publisher","unstructured":"Islam S, Espitia CM, Persky DO, Carew JS, Nawrocki ST (2021) Targeting JAK\/STAT signaling antagonizes resistance to oncolytic reovirus therapy driven by prior infection with HTLV-1 in models of T-Cell lymphoma. Viruses 13(7). https:\/\/doi.org\/10.3390\/v13071406","DOI":"10.3390\/v13071406"},{"key":"11513_CR20","doi-asserted-by":"publisher","unstructured":"Suzuki N, Yoshida T, Takeuchi H, Sakuma R, Sukegawa S, Yamaoka S (2018) Robust Enhancement of Lentivirus Production by Promoter Activation. Sci Rep-Uk 8. https:\/\/doi.org\/10.1038\/s41598-018-33042-5","DOI":"10.1038\/s41598-018-33042-5"},{"issue":"3","key":"11513_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1074-7613(00)00028-5","volume":"13","author":"XP Chen","year":"2000","unstructured":"Chen XP, Losman JA, Rothman PSOCS, Proteins (2000) Regulators of intracellular signaling. Immunity 13(3):287\u2013290. https:\/\/doi.org\/10.1016\/S1074-7613(00)00028-5","journal-title":"Immunity"},{"issue":"1","key":"11513_CR22","first-page":"1","volume":"2","author":"MC Trengove","year":"2013","unstructured":"Trengove MC, Ward AC (2013) SOCS proteins in development and disease. Am J Clin Experimental Immunol 2(1):1\u201329","journal-title":"Am J Clin Experimental Immunol"},{"key":"11513_CR23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1758-2652-15-10","volume":"15","author":"F Al-Ghazawi","year":"2012","unstructured":"Al-Ghazawi F, Parmar P, Faller E, Sugden S, Sant N, MacPherson P (2012) Suppressor of cytokine signalling (SOCS) proteins are induced by IL-7 and the interaction of SOCS proteins with the IL-7 receptor alpha (CD127) May play a role in regulating CD127 expression in human CD8 T cells. J Int Aids Soc 15:10","journal-title":"J Int Aids Soc"},{"key":"11513_CR24","doi-asserted-by":"publisher","first-page":"1449397","DOI":"10.3389\/fimmu.2024.1449397","volume":"15","author":"DM Lynch","year":"2024","unstructured":"Lynch DM, Forrester B, Webb T, Ciulli A (2024) Unravelling the druggability and immunological roles of the SOCS-family proteins. Front Immunol 15:1449397. https:\/\/doi.org\/10.3389\/fimmu.2024.1449397","journal-title":"Front Immunol"},{"key":"11513_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.05.020","author":"S Liu","year":"2025","unstructured":"Liu S, Wang M, Xu L, Deng D, Lu L, Tian J et al (2025) New insight into the role of SOCS family in immune regulation and autoimmune pathogenesis. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2025.05.020","journal-title":"J Adv Res"},{"issue":"1\u20132","key":"11513_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cyto.2009.07.201","volume":"48","author":"JCB Li","year":"2009","unstructured":"Li JCB, Cheng SM, Yim HCH, Lee DCW, Lau ASY (2009) Mechanisms underlying HIV-1 suppression of IFN\u03b3 signaling pathways: A role for transactivator Tat in the induction of SOCS-2 in primary human blood monocytes. Cytokine 48(1\u20132):63. https:\/\/doi.org\/10.1016\/j.cyto.2009.07.201","journal-title":"Cytokine"},{"issue":"1","key":"11513_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0145-2126(03)00158-9","volume":"28","author":"JH Cheng","year":"2004","unstructured":"Cheng JH, Zhang DS, Zhou CH, Marasco WA (2004) Down-regulation of SHP1 and up-regulation of negative regulators of JAK\/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4\u2009<\u2009SUP>+\u2009T-cells. Leuk Res 28(1):71\u201382. https:\/\/doi.org\/10.1016\/S0145-2126(03)00158-9","journal-title":"Leuk Res"},{"issue":"4","key":"11513_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1620\/tjem.204.289","volume":"204","author":"Y Nishiura","year":"2004","unstructured":"Nishiura Y, Nakamura T, Fukushima N, Moriuchi R, Katamine S, Eguchi K (2004) Increased mRNA expression of Th1-cytokine signaling molecules in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis. Tohoku J Exp Med 204(4):289\u2013298. https:\/\/doi.org\/10.1620\/tjem.204.289","journal-title":"Tohoku J Exp Med"},{"issue":"6","key":"11513_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/intimm\/dxh238","volume":"17","author":"H Hayase","year":"2005","unstructured":"Hayase H, Ishizu A, Ikeda H, Miyatake Y, Baba T, Higuchi M et al (2005) Aberrant gene expression by CD25\u2009<\u2009SUP>+CD4\u2009<\u2009SUP>+ immunoregulatory T cells in autoimmune-prone rats carrying the human T cell leukemia virus type-I gene. Int Immunol 17(6):677\u2013684. https:\/\/doi.org\/10.1093\/intimm\/dxh238","journal-title":"Int Immunol"},{"issue":"11","key":"11513_CR30","doi-asserted-by":"publisher","first-page":"e1001177","DOI":"10.1371\/journal.ppat.1001177","volume":"6","author":"S Oliere","year":"2010","unstructured":"Oliere S, Hernandez E, Lezin A, Arguello M, Douville R, Nguyen TL et al (2010) HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1). PLoS Pathog 6(11):e1001177. https:\/\/doi.org\/10.1371\/journal.ppat.1001177","journal-title":"PLoS Pathog"},{"key":"11513_CR31","doi-asserted-by":"publisher","unstructured":"Bergeron JRC, Huthoff H, Veselkov DA, Beavil RL, Simpson PJ, Matthews SJ et al (2010) The SOCS-Box of HIV-1 Vif Interacts with ElonginBC by Induced-Folding to Recruit Its Cul5-Containing Ubiquitin Ligase Complex. Plos Pathogens 6(6). https:\/\/doi.org\/10.1371\/journal.ppat.1000925","DOI":"10.1371\/journal.ppat.1000925"},{"issue":"3","key":"11513_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1532\/Ijh97.06013","volume":"83","author":"ES Ehrlich","year":"2006","unstructured":"Ehrlich ES, Yu XF (2006) Lentiviral vif: viral hijacker of the ubiquitin-proteasome system. Int J Hematol 83(3):208\u2013212. https:\/\/doi.org\/10.1532\/Ijh97.06013","journal-title":"Int J Hematol"},{"issue":"23","key":"11513_CR33","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1101\/gad.1249904","volume":"18","author":"A Mehle","year":"2004","unstructured":"Mehle A, Goncalves J, Santa-Marta M, McPike M, Gabuzda D (2004) Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev 18(23):2861\u20132866. https:\/\/doi.org\/10.1101\/gad.1249904","journal-title":"Genes Dev"},{"issue":"23","key":"11513_CR34","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1101\/gad.1250204","volume":"18","author":"YK Yu","year":"2004","unstructured":"Yu YK, Xiao ZX, Ehrlich ES, Yu XH, Yu XF (2004) Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Gene Dev 18(23):2867\u20132872. https:\/\/doi.org\/10.1101\/gad.1250204","journal-title":"Gene Dev"},{"key":"11513_CR35","doi-asserted-by":"publisher","unstructured":"Lu ZS, Bergeron JRC, Atkinson RA, Schaller T, Veselkov DA, Oregioni A et al (2013) Insight into the HIV-1 Vif SOCS-box-ElonginBC interaction. Open Biology 3(11). https:\/\/doi.org\/10.1098\/rsob.130100","DOI":"10.1098\/rsob.130100"},{"issue":"17","key":"11513_CR36","doi-asserted-by":"publisher","first-page":"8561","DOI":"10.1128\/Jvi.00960-10","volume":"84","author":"Y Dang","year":"2010","unstructured":"Dang Y, Wang XJ, York IA, Zheng YH (2010) Identification of a critical T(Q\/D\/E)xADx(I\/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity. J Virol 84(17):8561\u20138570. https:\/\/doi.org\/10.1128\/Jvi.00960-10","journal-title":"J Virol"},{"issue":"1","key":"11513_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.yexmp.2006.01.002","volume":"81","author":"AF Nicol","year":"2006","unstructured":"Nicol AF, Nuovo GJ, Wang Y, Grinsztejn B, Tristao A, Russomano F et al (2006) In situ detection of SOCS and cytokine expression in the uterine cervix from HIV\/HPV coinfected women. Exp Mol Pathol 81(1):42\u201347. https:\/\/doi.org\/10.1016\/j.yexmp.2006.01.002","journal-title":"Exp Mol Pathol"},{"key":"11513_CR38","doi-asserted-by":"publisher","unstructured":"YadavA, Reid WC (2006) Reduced CD4 type 1 cytokine response by HIV-1 Transgenic rat May be correlated with increased SOCS-1 expression from dendritic cells. Retrovirology. 2006 Dec 21;3(Suppl 1):S103.10.1186\/1742-4690-3-S1-S103. PMCID: PMC1716911 https:\/\/doi.org\/10.1186\/1742-4690-3-S1-S103","DOI":"10.1186\/1742-4690-3-S1-S103"},{"key":"11513_CR39","doi-asserted-by":"publisher","unstructured":"YadavA, Reid W (2007) Increased socs-1 expression in dendritic cells May be responsible for reduced type 1 cytokine responses in HIV-1 Transgenic rats. J Immunol, Volume 178, Issue 1_Supplement, April 2007, Pages S64\u2013S65, https:\/\/doi.org\/10.4049\/jimmunol.178.Supp.46.20","DOI":"10.4049\/jimmunol.178.Supp.46.20"},{"key":"11513_CR40","doi-asserted-by":"crossref","unstructured":"Anjana-Yadav, Reitz M, Reid WC (2008) Increased expression of Suppressor of Cytokine Signaling-1 (SOCS-1) by dendritic and CD4\u2009+\u2009T cells of HIV-1 transgenic rats: A mechanism for dysregulated T helper-1 responses. Faseb J 22","DOI":"10.1096\/fasebj.22.1_supplement.899.1"},{"key":"11513_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/01.qai.0000351170.33596.e9","volume":"51","author":"W Reid","year":"2009","unstructured":"Reid W (2009) Increased expression of suppressor of cytokine Signaling-1 (SOCS-1) by HIV-1 Transgenic rats: A mechanism for dysregulated T helper-1 responses. Jaids-J Acq Imm Def 51:141. https:\/\/doi.org\/10.1097\/01.qai.0000351170.33596.e9","journal-title":"Jaids-J Acq Imm Def"},{"issue":"1","key":"11513_CR42","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.virol.2008.11.039","volume":"385","author":"A Yadav","year":"2009","unstructured":"Yadav A, Fitzgerald P, Sajadi MM, Gilliam B, Lafferty MK, Redfield R et al (2009) Increased expression of suppressor of cytokine signaling-1 (SOCS-1): A mechanism for dysregulated T helper-1 responses in HIV-1 disease. Virology 385(1):126\u2013133. https:\/\/doi.org\/10.1016\/j.virol.2008.11.039","journal-title":"Virology"},{"issue":"2","key":"11513_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/Qai.0000000000002319","volume":"84","author":"M Hersberger","year":"2020","unstructured":"Hersberger M, Schlaepfer E, Buehler M, Bochud PY, Vernazza P, Marti-Jaun J et al (2020) Polymorphisms of SOCS-1 are associated with a rapid HIV progression rate. Jaids-J Acq Imm Def 84(2):189\u2013195. https:\/\/doi.org\/10.1097\/Qai.0000000000002319","journal-title":"Jaids-J Acq Imm Def"},{"issue":"4","key":"11513_CR44","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/eji.201041198","volume":"41","author":"RC Miller","year":"2011","unstructured":"Miller RC, Schlaepfer E, Baenziger S, Crameri R, Zeller S, Byland R et al (2011) HIV interferes with SOCS-1 and-3 expression levels driving immune activation. Eur J Immunol 41(4):1058\u20131069. https:\/\/doi.org\/10.1002\/eji.201041198","journal-title":"Eur J Immunol"},{"key":"11513_CR45","doi-asserted-by":"publisher","unstructured":"Subramanya S, Armant M, Kim S, Ye C, Leiberman J, Schultz L et al (2009) Priming with SOCS-1 silenced dendritic cells induces robust HIV-specific CTL response in a novel HLA-A2 Transgenic humanized mouse model. Retrovirology 6. https:\/\/doi.org\/10.1186\/1742-4690-6-S3-P420","DOI":"10.1186\/1742-4690-6-S3-P420"},{"issue":"11","key":"11513_CR46","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1038\/mt.2010.148","volume":"18","author":"S Subramanya","year":"2010","unstructured":"Subramanya S, Armant M, Salkowitz JR, Nyakeriga AM, Haridas V, Hasan M et al (2010) Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 SiRNA. Mol Ther 18(11):2028\u20132037. https:\/\/doi.org\/10.1038\/mt.2010.148","journal-title":"Mol Ther"},{"key":"11513_CR47","doi-asserted-by":"publisher","unstructured":"Subramanya S, Ye CH, Kim SS, Shankar P (2010) Enhanced induction of HIV-specific CTL by dendritic cell-targeted delivery of SOCS-1 siRNA. Retrovirology 7:19 https:\/\/doi.org\/10.1186\/1742-4690-7-S1-P12","DOI":"10.1186\/1742-4690-7-S1-P12"},{"issue":"3","key":"11513_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2174\/138955708783744047","volume":"8","author":"T Izumi","year":"2008","unstructured":"Izumi T, Shirakawa K, Takaori-Kondo A (2008) Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy. Mini-Rev Med Chem 8(3):231\u2013238","journal-title":"Mini-Rev Med Chem"},{"issue":"7","key":"11513_CR49","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/eji.201343748","volume":"43","author":"M Kubo","year":"2013","unstructured":"Kubo M (2013) Therapeutic hope for psoriasis offered by SOCS (suppressor of cytokine signaling) mimetic peptide. Eur J Immunol 43(7):1702\u20131705. https:\/\/doi.org\/10.1002\/eji.201343748","journal-title":"Eur J Immunol"},{"issue":"5","key":"11513_CR50","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/eji.201344369","volume":"44","author":"Y Liang","year":"2014","unstructured":"Liang Y, Xu WD, Peng H, Pan HF, Ye DQ (2014) SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications. Eur J Immunol 44(5):1265\u20131275. https:\/\/doi.org\/10.1002\/eji.201344369","journal-title":"Eur J Immunol"},{"key":"11513_CR51","doi-asserted-by":"publisher","unstructured":"Eom Y, Eom SY, Lee J, Hwang S, Won J, Kim H et al (2023) Therapeutic effects and underlying mechanism of SOCS-com Gene-Transfected ADMSCs in pressure ulcer mouse models. Cells 12(14). https:\/\/doi.org\/10.3390\/cells12141840","DOI":"10.3390\/cells12141840"},{"issue":"2","key":"11513_CR52","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1021\/acsabm.2c00963","volume":"6","author":"K Sumiya","year":"2023","unstructured":"Sumiya K, Izumi H, Sakurai K (2023) Enhanced therapeutic efficacy of immunostimulatory CpG-ODN by Silencing SOCS-1 with Polysaccharide\/miR-155 complexes. ACS Appl Bio Mater 6(2):774\u2013783. https:\/\/doi.org\/10.1021\/acsabm.2c00963","journal-title":"ACS Appl Bio Mater"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11513-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:40:00Z","timestamp":1770288000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11513-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11513"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11513-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is an observational study. The UNAM Research Ethics Committee has confirmed that no ethical approval is required for this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"366"}}